{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T23:48:45Z","timestamp":1790034525372,"version":"4.0.1"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T00:00:00Z","timestamp":1729468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Previous studies have suggested a potential association between gut microbiota and the development of alcohol-related liver disease (ALD). However, the causal relationship between gut microbiota and ALD, as well as the role of inflammatory cytokines as mediators, remains unclear. This study aims to explore the causal relationship between gut microbiota and ALD using Mendelian randomization (MR) methods, and to analyze the mediating role of inflammatory cytokines.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Gut microbiota, 91 inflammatory cytokines, and ALD were identified from summary data of large-scale genome-wide association studies (GWAS). MR was employed to investigate the causal relationship between gut microbiota, cytokines, and ALD, with the inverse variance-weighted method (IVW) as the primary statistical approach. Additionally, we examined whether inflammatory cytokines act as mediating factors in the pathway from gut microbiota to ALD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The IVW results confirmed two positive and one negative causal effect between genetic liability in the gut microbiota and ALD. <jats:italic>Escherichia coli<\/jats:italic> (<jats:italic>P<\/jats:italic>= 0.003) was identified as a protective factor for ALD, while <jats:italic>Roseburia hominis<\/jats:italic> (<jats:italic>P<\/jats:italic>=0.023) and <jats:italic>Family Porphyromonadaceae<\/jats:italic> (<jats:italic>P<\/jats:italic>=0.038) were identified as risk factors for ALD. Furthermore, there were five positive and two negative causal effects between inflammatory cytokines and ALD, with CUB domain-containing protein 1 (P= 0.035), Macrophage colony-stimulating factor 1 (P=0.047), Cystatin D (P = 0.035), Fractalkine (P=0.000000038), Monocyte chemoattractant protein-1 (P=0.004) positively associated with ALD onset. CD40L receptor (P= 0.044) and Leukemia inhibitory factor (P = 0.024) exhibited protective effects against ALD. Mediation MR analysis indicated that CUB domain-containing protein 1 (mediation proportion=1.6%, P=0.035), Cystatin D (mediation proportion=1.5%, P=0.012), and Monocyte chemoattractant protein-1 (mediation proportion=3.3%, P=0.005) mediated the causal effect of <jats:italic>Roseburia hominis<\/jats:italic> on ALD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In conclusion, our study supports a causal relationship among gut microbiota, inflammatory cytokines and ALD, with inflammatory cytokines potentially acting as mediating factors in the pathway from gut microbiota to ALD.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2024.1442603","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T04:31:32Z","timestamp":1729485092000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Causal relationships between the gut microbiota, inflammatory cytokines, and alcoholic liver disease: a Mendelian randomization analysis"],"prefix":"10.3389","volume":"15","author":[{"given":"Shanzheng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sutong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangkai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,10,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41572-018-0014-7","article-title":"Alcoholic liver disease","volume":"4","author":"Seitz","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"B2","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.cmet.2022.05.003","article-title":"Changing global epidemiology of liver cancer from 2010 to 2019: nash is the fastest growing cause of liver cancer","volume":"34","author":"Huang","year":"2022","journal-title":"Cell Metab"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories1990-2019: A systematic analysis for the global burden of disease study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathmechdis-031521-030435","article-title":"Recent advances in understanding of pathogenesis of alcohol-associated liver disease","volume":"18","author":"Wu","year":"2023","journal-title":"Annu Rev Pathol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2014.01.005","article-title":"Liver regeneration","volume":"163","author":"Mao","year":"2014","journal-title":"Transl Res"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2020.07.007","article-title":"Microbiota and fatty liver disease-the known, the unknown, and the future","volume":"28","author":"Lang","year":"2020","journal-title":"Cell Host Microbe"},{"key":"B7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.phrs.2012.10.007","article-title":"Modulation of intestinal barrier by intestinal microbiota: pathological and therapeutic implications","volume":"69","author":"Natividad","year":"2013","journal-title":"Pharmacol Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/ijms21176402","article-title":"Gut microbiota and intestinal trans-epithelial permeability","volume":"21","author":"Allam-Ndoul","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1003376","article-title":"The role of gut microbiota in liver regeneration","volume":"13","author":"Xu","year":"2022","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41423-020-00592-6","article-title":"Gut microbiome, liver immunology, and liver diseases","volume":"18","author":"Wang","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1136\/gutjnl-2016-313432","article-title":"Recovery of ethanol-induced akkermansia muciniphila depletion ameliorates alcoholic liver disease","volume":"67","author":"Grander","year":"2018","journal-title":"Gut"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1742-x","article-title":"Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease","volume":"575","author":"Duan","year":"2019","journal-title":"Nature"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2022.09.017","article-title":"Gut-liver axis: pathophysiological concepts and clinical implications","volume":"34","author":"Tilg","year":"2022","journal-title":"Cell Metab"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.17219","article-title":"Mendelian randomization","volume":"318","author":"Emdin","year":"2017","journal-title":"Jama"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k601","article-title":"Reading mendelian randomisation studies: A guide, glossary, and checklist for clinicians","volume":"362","author":"Davies","year":"2018","journal-title":"Bmj"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.v10.4","article-title":"Meta-analysis and mendelian randomization: A review","volume":"10","author":"Bowden","year":"2019","journal-title":"Res Synth Methods"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05473-8","article-title":"Finngen provides genetic insights from A well-phenotyped isolated population","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-021-00992-y","article-title":"Effect of host genetics on the gut microbiome in 7,738 participants of the dutch microbiome project","volume":"54","author":"Lopera-Maya","year":"2022","journal-title":"Nat Genet"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-023-01588-w","article-title":"Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets","volume":"24","author":"Zhao","year":"2023","journal-title":"Nat Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-019-0350-x","article-title":"Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases","volume":"51","author":"Sanna","year":"2019","journal-title":"Nat Genet"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.34408","article-title":"The mr-base platform supports systematic causal inference across the human phenome","volume":"7","author":"Hemani","year":"2018","journal-title":"Elife"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/gepi.2013.37.issue-7","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet Epidemiol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-017-0255-x","article-title":"Interpreting findings from mendelian randomization using the mr-egger method","volume":"32","author":"Burgess","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from mendelian randomization between complex traits and diseases","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyq151","article-title":"Power and instrument strength requirements for mendelian randomization studies using multiple genetic variants","volume":"40","author":"Pierce","year":"2011","journal-title":"Int J Epidemiol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00245.2016","article-title":"Precision medicine in alcoholic and nonalcoholic fatty liver disease via modulating the gut microbiota","volume":"311","author":"Bluemel","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.202200164","article-title":"Roseburia hominis alleviates neuroinflammation via short-chain fatty acids through histone deacetylase inhibition","volume":"66","author":"Song","year":"2022","journal-title":"Mol Nutr Food Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-304833","article-title":"A decrease of the butyrate-producing species roseburia hominis and faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis","volume":"63","author":"Machiels","year":"2014","journal-title":"Gut"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01166","article-title":"Human gut symbiont roseburia hominis promotes and regulates innate immunity","volume":"81166","author":"Patterson","year":"2017","journal-title":"Front Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/nu14010117","article-title":"Roseburia hominis increases intestinal melatonin level by activating P-creb-aanat pathway","volume":"14","author":"Song","year":"2021","journal-title":"Nutrients"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgg.2021.12.007","article-title":"The gut microbiome and microbial metabolites in acute myocardial infarction","volume":"49","author":"Liu","year":"2022","journal-title":"J Genet Genomics"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12974-023-02999-0","article-title":"Gut microbiota, circulating cytokines and dementia: A mendelian randomization study","volume":"21","author":"Ji","year":"2024","journal-title":"J Neuroinflamm"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-20-2978","article-title":"The cdcp1 signaling hub: A target for cancer detection and therapeutic intervention","volume":"81","author":"Khan","year":"2021","journal-title":"Cancer Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.335448","article-title":"The cell surface glycoprotein cub domain-containing protein 1 (Cdcp1) contributes to epidermal growth factor receptor-mediated cell migration","volume":"287","author":"Dong","year":"2012","journal-title":"J Biol Chem"},{"key":"B36","doi-asserted-by":"publisher","first-page":"5","DOI":"10.18632\/oncoscience.v3i1","article-title":"New crossroads for potential therapeutic intervention in cancer - intersections between cdcp1, egfr family members and downstream signaling pathways","volume":"3","author":"He","year":"2016","journal-title":"Oncoscience"},{"key":"B37","doi-asserted-by":"publisher","first-page":"101257","DOI":"10.1016\/j.xcrm.2023.101257","article-title":"Identification and multicentric validation of soluble cdcp1 as A robust serological biomarker for risk stratification of nash in obese chinese","volume":"4","author":"Jia","year":"2023","journal-title":"Cell Rep Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1172\/JCI37205","article-title":"Cystatin D is A candidate tumor suppressor gene induced by vitamin D in human colon cancer cells","volume":"119","author":"Alvarez-D\u00edaz","year":"2009","journal-title":"J Clin Invest"},{"key":"B39","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3892\/or.2019.7154","article-title":"Investigation of the clinical significance and prospective molecular mechanisms of cystatin genes in patients with hepatitis B virus\u2212Related hepatocellular carcinoma","volume":"42","author":"Zhou","year":"2019","journal-title":"Oncol Rep"},{"key":"B40","doi-asserted-by":"publisher","first-page":"107598","DOI":"10.1016\/j.intimp.2021.107598","article-title":"Mcp-1: function, regulation, and involvement in disease","volume":"101","author":"Singh","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.165369","article-title":"Notch-mediated hepatocyte mcp-1 secretion causes liver fibrosis","volume":"8","author":"Kang","year":"2023","journal-title":"JCI Insight"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-019-03255-6","article-title":"Dual ccr5\/ccr2 targeting: opportunities for the cure of complex disorders","volume":"76","author":"Fantuzzi","year":"2019","journal-title":"Cell Mol Life Sci"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/acer.2014.38.issue-5","article-title":"Cerebrospinal fluid monocyte chemoattractant protein-1 in alcoholics: support for A neuroinflammatory model of chronic alcoholism","volume":"38","author":"Umhau","year":"2014","journal-title":"Alcohol Clin Exp Res"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.985729","article-title":"Exploring causal correlations between inflammatory cytokines and systemic lupus erythematosus: A mendelian randomization","volume":"13","author":"Xiang","year":"2022","journal-title":"Front Immunol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1442603\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T04:31:34Z","timestamp":1729485094000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1442603\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,21]]},"references-count":44,"alternative-id":["10.3389\/fendo.2024.1442603"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2024.1442603","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,21]]},"article-number":"1442603"}}